AIM
MDGL icon

AXA Investment Managers’s Madrigal Pharmaceuticals MDGL Stock Holding History

AXA Investment Managers’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$6.9M Buy
+15,036
New +$5.61M 0.02% 497

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AXA Investment Managers's MDGL Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Madrigal Pharmaceuticals (MDGL) in Q3 2025: 15,036 shares worth $6.9M. The stake represents 0.02% of the portfolio and ranks #497 among its holdings.

352 funds tracked by Wall St. Rank hold MDGL as of Q3 2025.

  • AXA Investment Managers held 15,036 shares of Madrigal Pharmaceuticals worth $6.9M as of Q3 2025.
  • Madrigal Pharmaceuticals was a new AXA Investment Managers position in Q3 2025.
  • Madrigal Pharmaceuticals made up 0.02% of AXA Investment Managers's portfolio in Q3 2025, its #497 holding.
  • 352 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.